Antidermatophytic action of resorcinol derivatives: Ultrastructural evidence of the activity of phenylethyl resorcinol against microsporum gypseum by Romagnoli, Carlo et al.
molecules
Article
Antidermatophytic Action of Resorcinol Derivatives:
Ultrastructural Evidence of the Activity of
Phenylethyl Resorcinol against
Microsporum gypseum
Carlo Romagnoli 1, Anna Baldisserotto 2, Chiara B. Vicentini 2, Donatella Mares 2,
Elisa Andreotti 1, Silvia Vertuani 2 and Stefano Manfredini 2,*
1 Department of Life Sciences, University of Modena and Reggio Emilia, Viale Caduti in Guerra 127,
41121 Modena, Italy; carlo.romagnoli@unimore.it (C.R.); elisa.andreotti@unimore.it (E.A.)
2 Department of Life Sciences and Biotechnology, Master Course in Cosmetic Science and Technology,
University of Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy; bldnna@unife.it (A.B.);
chiara.vicentini@unife.it (C.B.V.); donatella.mares@unife.it (D.M.); silvia.vertuani@unife.it (S.V.)
* Correspondence: mv9@unife.it; Tel.: +39-0532-455294; Fax: +39-0532-455378
Academic Editor: Diego Muñoz-Torrero
Received: 14 July 2016; Accepted: 27 September 2016; Published: 30 September 2016
Abstract: In this work, we evaluated the antidermatophytic activities of three resorcinol derivatives
that have a history of use in dermo-cosmetic applications to discover molecules with multiple
dermatological activities (i.e., multi-target drugs), thereby reducing the cost and time necessary
for new drug development. The antidermatophytic activities of the three skin lighteners were
evaluated relative to the known antifungal drug fluconazole on nine dermatophytes responsible for
the most common dermatomycoses: Microsporum gypseum, Microsporum canis, Trichophyton violaceum,
Arthroderma cajetani, Trichophyton mentagrophytes, Epidermophyton floccosum, Nannizzia gypsea,
Trichophyton rubrum and Trichophyton tonsurans. Among the three tested resorcinols, only two
showed promising properties, with the ability to inhibit the growth of all tested dermatophytes;
additionally, the IC50 values of these two resorcinols against the nine dermatophytes confirmed their
good antifungal activity, particularly for phenylethyl resorcinol against M. gypseum. Ultrastructural
alterations exhibited by the fungus were observed using scanning electron microscopy and
transmission electron microscopy and reflected a dose-dependent response to treatment with the
activation of defence and self-preservation strategies.
Keywords: resorcinol derivatives; dermatophytes; Microsporum gypseum; antifungal activity;
TEM; SEM
1. Introduction
We recently initiated a systematic study [1] that utilizes a multi-target drug discovery approach to
discover new molecules with antifungal activities among drugs already used for other dermatological
applications. The objective of this study is to discover novel antifungals with low toxicity, as proven
by their long history of dermatological use. In particular, our attention was drawn to resorcinols,
which are naturally occurring phenolic compounds that are mainly synthesized by plants; these
molecules are widely used in the dermatology and cosmetic fields as skin lighteners and have a very
good safety profile.
Resorcinol has a long history of therapeutic use for its keratolytic properties [2] and has been
included, usually with sulphur, in topical preparations for the treatment of acne and seborrhoeic skin
conditions, although other treatments are generally preferred [2].
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Resorcinol is one of the components in the well-known Castellani’s solution, which was developed
in 1905 by Aldo Castellani, an Italian doctor [3]. The traditional Castellani’s solution contains boric
acid, phenol, fuchsine, resorcinol, acetone, alcohol and water. Its antifungal activity is attributed
to fuchsine, and its antibacterial activity is ascribed to ethanol. However, the role of resorcinol is
also intriguing. In fact, in the last few years, increasing data have indicated that the compound has
various biological activities, including antimicrobial, antiparasitic and cytotoxic activities [4,5], such as
antioxidant (anti-inflammatory) and antigenotoxic activities [6].
We selected three compounds in this class—(±)phenylethylresorcinol (1), 4-hexylresorcinol (2)
and 4-butylresorcinol (3) (Figure 1)—based on their widespread use in dermatology and investigated
their effects against nine dermatophytes. To the best of our knowledge, these compounds are not
currently used as anti-dermatophytes, and rather they are currently employed as skin-lightening
agents because they inhibit tyrosinase [7,8].
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Figure 1. Chemical structures of (±)-phenylethylresorcinol (1), 4-hexylresorcinol (2) and 4-butyl-
resorcinol (3). 
The results of a preliminary screening were encouraging: plate tests and germination tests 
showed good activity, with high inhibition rates against many fungi. These favourable data emphasized 
the need for a deeper investigation of the antifungal activities of these substances, including determination 
of their IC50 values, which reflect the effectiveness of a compound. These measurements were made 
for the two compounds that gave the best preliminary results. 
Subsequently, the mechanism of action of the most active molecule, phenylethylresorcinol, 
against Microsporum gypseum (Bodin) Guiart & Grigorakis, was investigated by electron microscopy. 
This fungus was chosen based on its IC50 values. The IC50 values of the selected resorcinols against 
M. gypseum were the lowest among all the fungi tested, indicating that this organism is highly 
sensitive to the treatment. 
M. gypseum is a geophilic fungus. It is a component of the complex soil mycoflora and is 
frequently found in soils rich in organic matter. It is distributed worldwide and infects humans, 
particularly children and rural workers during warm humid weather, producing circinate herpes and 
tinea capitis [9,10]. 
Lesions caused by M. gypseum frequently induce strong inflammatory reactions that mimic 
dermatitis. This dermatitis is often treated with steroids to reduce inflammation, resulting in an 
atypical appearance as tinea. It must also be noted that the risks associated with modern lifestyle 
activities, e.g., cosmetic tattooing and pet keeping, have increased interest in the discovery of novel 
multi-target drugs against M. gypseum [11]. 
The available literature on M. gypseum is fairly sparse. In the current study, we investigated the 
fungus using scanning electron microscopy and transmission electron microscopy (SEM and TEM, 
respectively). 
2. Results 
2.1. Antifungal Activity 
Table 1 shows the growth inhibition induced by the three tested resorcinol derivatives against 
nine dermatophytes. Notably, 4-butylresorcinol showed only low inhibition against three 
dermatophytes (M. gypseum, T. mentagrophytes and E. floccosum), even at the two highest doses. 
  
Figure 1. Chemical structures of (±)-phenylethylresorcinol (1), 4-hexylresorcinol (2) and
4-butyl-resorcinol (3).
The results of a preliminary screening were encouraging: plate tests and germination tests showed
good activity, with high inhibition rates against many fungi. These favourable data emphasized the
need for a deeper investigation of the antifungal activities of these substances, including determination
of their IC50 values, which reflect the effectiveness of a compound. These measurements were made
for the two compounds that gave the best preliminary results.
Subsequently, the mechanism of action of the most active molecule, phenylethylresorcinol,
against Microsporum gypseum (Bodin) Guiart & Grigorakis, was investigated by electron microscopy.
This fungus was chosen based on its IC50 values. The IC50 values of the selected resorcinols against
M. gypseum were the lowest among all the fungi tested, indicating that this organism is highly sensitive
to the treatment.
M. gypseum is a geophilic fungus. It is a component of the complex soil mycoflora and is frequently
found in soils rich in organic matter. It is distributed worldwide and infects humans, particularly
children and rural workers during warm humid weather, producing circinate herpes and tinea capitis [9,10].
Lesions caused by M. gypseum frequently induce strong inflammatory reactions that mimic
dermatitis. This dermatitis is often treated with steroids to reduce inflammation, resulting in an
atypical appearance as tinea. It must also be noted that the risks associated with modern lifestyle
activities, e.g., cosmetic tattooing and pet keeping, have increased interest in the discovery of novel
multi-target drugs against M. gypseum [11].
The available literature on M. gypseum is fairly sparse. In the current study, we investigated




Table 1 shows the growth inhibition induced by the three tested resorcinol derivatives against nine
dermatophytes. Notably, 4-butylresorcinol showed only low inhibition against three dermatophytes
(M. gypseum, T. mentagrophytes and E. floccosum), even at the two highest doses.
Molecules 2016, 21, 1306 3 of 12
Table 1. Percentage of growth inhibition induced by the three tested resorcinol derivatives against nine
dermatophytes after seven days of treatment at 5, 10, 20, 50, 100 and 200 µg/mL. Each value is the
mean of three measurements (all standard deviation values, not reported, were within 10%).
Compound 5 µg/mL 10 µg/mL 20 µg/mL 50 µg/mL 100 µg/mL 200 µg/mL
M. gypseum
4-Hexylresorcinol 5.5 21.12 71.5 88.32 93.46 94.57
Phenylethylresorcinol 20.99 34.16 54.73 75.31 98.51 99.50
4-Butylresorcinol 25.00 33.33
M. canis
4-Hexylresorcinol 17.5 32.5 82.5 85 92.68 97.5
Phenylethylresorcinol + + 10 47.5 94.74 95
4-Butylresorcinol + +
T. violaceum
4-Hexylresorcinol 12.46 21.45 37.02 59.21 63.16 66.09
Phenylethylresorcinol 0.97 3.38 5.80 31.40 68.92 100
4-Butylresorcinol + +
A. cajetani
4-Hexylresorcinol 18.11 43.31 69.29 74.02 78.13 82.29
Phenylethylresorcinol + 13.77 39.86 67.39 84.56 100
4-Butylresorcinol + +
T. mentagrophytes
4-Hexylresorcinol 31.48 43.52 81.08 82.41 87.04 88.89
Phenylethylresorcinol 5.88 10.92 36.13 93.28 99.16 100
4-Butylresorcinol 16.67 45
E. floccosum
4-Hexylresorcinol 5.73 20.31 50.00 69.27 78.13 86.40
Phenylethylresorcinol 22.42 24.66 36.32 47.09 66.28 85.82
4-Butylresorcinol 12.61 19.82
N. gypsea
4-Hexylresorcinol 13.61 19.73 53.74 76.19 83.67 85.47
Phenylethylresorcinol 11.56 16.76 31.21 50.87 82.66 97.78
4-Butylresorcinol + 21.43
T. rubrum
4-Hexylresorcinol 28.95 38.16 59.65 73.68 78.95 81.90
Phenylethylresorcinol 18.41 26.37 39.30 65.17 70.12 81.33
4-Butylresorcinol + 5.86
T. tonsurans
4-Hexylresorcinol 4.6875 18.75 75 85.94 92.19 93.10
Phenylethylresorcinol 12.5 14.0625 37.5 89.0625 100 100
4-Butylresorcinol + +
+ the substance showed an hormone-like effect with a fungal growth higher than that of the controls.
Both 4-hexylresorcinol and phenylethylresorcinol generally showed very good antifungal activity
against the nine dermatophytes at all concentrations. Both substances exhibited nearly 50% inhibition
of almost all fungi, even at a concentration of 50 µg/mL; however, against M. gypseum, both exceeded
50% inhibition at a concentration of 20 µg/mL. Only phenylethylresorcinol achieved 100% inhibition at
the highest concentration against three dermatophytes (T. violaceum, A. cajetani and T. mentagrophytes),
whereas against T. tonsurans, it caused 100% inhibition at concentrations as low as 100 µg/mL.
Based on these results, we decided to more thoroughly investigate phenylethylresorcinol.
This compound may be of potential use in antifungal therapy because of its increased activity against
the nine dermatophytes tested, shown in Table 2, in comparison with that of the well-known antifungal
agent fluconazole. The results clearly show that fluconazole was less active than phenylethyl-resorcinol.
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Table 2. Percent growth inhibition induced by phenylethylresorcinol on nine dermatophytes after
seven days of treatment at 5, 10, 20, 50, 100 and 200 µg/mL. The percent growth inhibition induced
by fluconazole is shown for comparison purposes. Each value is the mean of three measurements
(all standard deviation values, which are not reported, were within 10%).
Compound 5 µg/mL 10 µg/mL 20 µg/mL 50 µg/mL 100 µg/mL 200 µg/mL
M. gypseum
Fluconazole 12.34 34.54 55.12 76.01 80.23 85.40
Phenylethyl resorcinol 19.65 35.48 58.12 74.07 97.98 99.02
M. canis
Fluconazole 17.12 26.48 39.95 61.87 80.43 88.51
Phenylethyl resorcinol + + 11.32 46.80 93.54 96.11
T. violaceum
Fluconazole 36.76 67.65 83.78 81.33 97.08 94.65
Phenylethylresorcinol 1.13 5.43 6.02 27.58 69.05 100
A. cajetani
Fluconazole 0.0 0.0 0.0 0.0 0.0 8.67
Phenylethylresorcinol + 13.77 39.86 67.39 84.56 100
T. mentagrophytes
Fluconazole 62.46 79.67 100 100 100 100
Phenylethylresorcinol 7.31 11.96 35.56 94.00 98.00 100
E. floccosum
Fluconazole 98.00 100 100 100 100 100
Phenylethylresorcinol 21.79 25.11 39.87 46.87 68.53 87.67
N. gypsea
Fluconazole 0.0 0.0 0.0 0.0 1.09 5.78
Phenylethylresorcinol 13.43 18.99 35.11 50.95 83.74 98.89
T. rubrum
Fluconazole 13.13 25.66 40.44 58.76 68.68 76.06
Phenylethylresorcinol 17.15 28.55 39.92 64.69 72.34 84.48
T. tonsurans
Fluconazole 27.77 48.56 44.12 72.33 71.33 79.90
Phenylethylresorcinol 13.17 16.44 35.57 89.74 100 100
+ the substance showed an hormone-like effect with a fungal growth higher than that of the controls.
In addition, the two resorcinol derivatives identified as the most active in the previous screening
were also evaluated for their potency, as reported in Table 3.
Table 3. IC50 values of 4-hexylresorcinol and phenylethylresorcinol against nine dermatophytes.




M. gypseum 18.77 11.42
M. canis 14.02 43.47
T. violaceum 48.39 54.60
A. cajetani 16.22 30.87
T. mentagrophytes 12.97 24.68
E. floccosum 29.42 37.40
N. gypsea 24.72 33.64
T. rubrum 16.22 31.42
T. tonsurans 20.09 23.24
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The IC50 values were low for almost all tested fungi. T. violaceum was the least inhibited with
phenylethyl resorcinol, whereas the most inhibited fungi was M. gypseum (11.42 µg/mL).
2.2. Inhibition of Spore Germination by Resazurin Assay
As M. gypseum was the most sensitive fungus to the three substances, it was tested for spore
germination inhibition. As shown in Table 4, the results of the test confirmed the excellent inhibitory
capacities of phenylethylresorcinol and 4-hexylresorcinol, as evidenced by the blue staining of the
cuvettes, which indicated the absence of viable spores (Figure 2).
Table 4. Resazurin assay. Percentage inhibition of spore germination after treatment with three
resorcinols at doses of 100 and 200 µg/mL.
Compound Concentration % Inhibition of Spore Germination
4-Hexylresorcinol 100 µg/mL 100
200 µg/mL 100
Phenylethylresorcinol 100 µg/mL 100
200 µg/mL 100
4-Butylresorcinol 100 µg/mL 13.5 ± 0.8
200 µg/mL 80.2 ± 1.1
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In contrast, 4-butylresorcinol inhibited spores germination at different stages, as indicated by 
the pinkish colour of the test cuvettes. Given these results, we chose the most active compound 
(phenylethylresorcinol) and the most sensitive fungus (M. gypseum) for electron microscopic 
evaluations. 
2.3. SEM Observations 
The control mycelium of M. gypseum, (Figure 3A) showed a typical morphology, exhibiting 
lengthened hyphae of constant diameter with a rounded or lightly tapering apex and smooth external 
surface. No microconidia or macroconidia were visible (Figure 3B) in the mycelium, as is expected 
for a young culture of 24 h. 
In samples treated with 20 μg/mL phenylethylresorcinol, the appearance of the mycelium was 
similar to that of the controls, except for the numerous microconidia (Figure 3C). In contrast, at 100 
μg/mL, the microconidia were no longer visible, although the mycelium contained abundant 
macroconidia (Figure 3D) showing the typical “cigar shape” with characteristic knobs on the outer 
surface (Figure 3E). 
These alterations on M. gypseum treated with phenylethylresorcinol are very interesting because 
they potentially reflect the development of defence strategies. As reported in the literature on other 
dermatophytes [12], an increase in the number of reproductive structures represents a defensive 
response by the microorganism. The production of microconidia or macroconidia is a form of asexual 
reproduction that occurs in an attempt to overcome nutrient starvation [13]. 
Figure 2. Colours of the cuvettes after the resazurin assay. Legend: 1—negative control;
2—positive control; 3—phenylethylresorcinol (200 µg/mL); 4—phen lethylresorcinol (100 µg/mL);
5—4-hexylresorcinol (200 µg/ L); 6—4-hexylresorcinol (200 µg/mL); 7—4-butyl-resorcinol
(200 µg/mL); 8—4-butylresorcinol (100 µg/mL).
In contrast, 4-butylresorcinol inhibited spores germination at different stages, as indicated by
the pinkish colour of the test cuvettes. Given these results, we chose the most active compound
(phenylethylresorcinol) and the most sensitive fungus (M. gypseum) for electron microscopic evaluations.
2.3. SEM Observations
The control mycelium of M. gypseum, (Figure 3A) showed a typical morphology, exhibiting
lengthened hyphae of constant diameter with a rounded or lightly tapering apex and smooth external
surface. No microconidia or macroconidia were visible (Figure 3B) in the mycelium, as is expected for
a young culture of 24 h.
In samples treated with 20 µg/mL phenylethylresorcinol, the appearance of the mycelium
was similar to that of the controls, except for the numerous microconidia (Figure 3C). In contrast,
at 100 µg/mL, the microconidia were no longer visible, although the mycelium contained abundant
macroconidia (Figur 3D) showing the typical “cigar shape” with characteristic knobs on the outer
surface (Figure 3E).
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At the lower doses tested, the substances only exhibited fungistatic activities, concordant with 
the literature on the antifungal activities of resorcinol derivatives against phytopathogens [6]. 
Conversely, at the highest concentration tested (200 μg/mL), the mycelium presented notable 
morphological abnormalities. This concentration probably overwhelms the defensive capabilities of 
the fungus, inducing the rupture or bursting of its defensive structures. At low magnification, the 
mycelium appears highly compact (Figure 4A), with hyphae fused together to form a singular woven 
structure that is occasionally interrupted by areas with the appearance of "stretch marks". Neither 
micro- nor macroconidia are visible, but in addition to crushed and very suppressed hyphae, strange 
formations with the appearance of burst balloons can be observed (Figure 4B). 
At the highest resolution (Figure 4C), in the layers underlying the cave formations, a type of 
trabecula can be observed that seems to be derived from the fusion of hyphae. The presence of 
material with a “spongy” consistency in some of these abnormal bodies exhibiting several openings 
is noteworthy. 
In Figure 4D one of these bodies has on its outer surface the typical roughness or blebbing of 
macroconidia. The highest concentration of phenylethylresorcinol (200 μg/mL) may have exerted a 
fungicidal action by blocking fungal defence strategies. 
Figure 3. (A) Control M. gypseum: detail of straight apex with smooth wall. SEM. Scale bar: 1 µm;
(B) Same sample: mycelium without visible microconidia. SEM. Scale bar: 20 µm; (C) M. gypseum
treated with 20 µg/mL phenylethylresorcinol: microconidia are visible. SEM. Scale bar: 10 µm;
(D) M. gypseum treated with 100 µg/mL phenylethylresorcinol: numerous macroconidia in the
mycelium. SEM. Scale bar: 20 µm; (E) Same sample: typical cigar-shaped macroconidium with
knobs on the surface. SEM. Scale bar: 2 µm.
These alterations on M. gypseum treated with phenylethylresorcinol are very interesting because
they potentially reflect the development of defence strategies. As reported in the literature on other
dermatophytes [12], an increase in the number of reproductive structures represents a defensive
response by the microorganism. The production of microconidia or macroconidia is a form of asexual
reproduction that occurs in an attempt to overcome nutrient starvation [13].
At the lower doses tested, the substances only exhibited fungistatic activities, concordant with the
literature on the antifungal activities of resorcinol derivatives against phytopathogens [6]. Conversely,
at the highest concentration tested (200 µg/mL), the mycelium presented notable morphological
abnormalities. This concentration probably overwhelms the defensive capabilities of the fungus,
inducing the rupture or bursting of its defensive structures. At low magnification, the mycelium
appears highly compact (Figure 4A), with hyphae fused together to form a singular woven structure
that is occasionally interrupted by areas with the appearance of “stretch marks”. Neither micro- nor
macroconidia are visible, but in addition to crushed and very suppressed hyphae, strange formations
with the appearance of burst balloons can be observed (Figure 4B).
At the highest resolution (Figure 4C), in the layers underlying the cave formations, a type of
trabecula can be observed that seems to be derived from the fusion of hyphae. The presence of
material with a “spongy” consistency in some of these abnormal bodies exhibiting several openings
is noteworthy.
In Figure 4D one of these bodies has on its outer surface the typical roughness or blebbing of
macroconidia. The highest concentration of phenylethylresorcinol (200 µg/mL) may have exerted
a fungicidal action by blocking fungal defence strategies.
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phenylethylresorcinol. Glycogen, which is no longer arranged in rosettes, is scattered throughout the 
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In the samples treated with the lowest concentration of phenylethylresorcinol (20 μg/mL), the 
most evident feature is the increased number of large vacuoles. Glycogen, which is no longer visible 
as rosettes, is scattered throughout the cytoplasm (Figure 5B), and some normally structured 
mitochondria are visible. 
At 100 μg/mL, many smaller vacuoles are present and contain non-electron-dense materials. 
Glycogen is distributed in the cytoplasm, accumulating near the vacuoles (Figure 6A). The TEM 
images also show ultrastructural changes reflecting the defensive efforts of the fungus. Notably, the 
Figure 4. M. gypseum treated with 200 µg/mL phenylethylresorcinol. (A) Compact mycelium with
hyphae fused together and some stretch marks. SEM. Scale bar: 10 µm; (B) Strange formations
in the compact mycelium with the appearance of burst balloons. SEM. Scale bar: 2 µm; (C) Cave
formations, probably derived from hyphae fusion, with spongy material visible inside. SEM. Scale bar:
2 µm; (D) High magnification of one of the exploded structures, showing the typical roughness of
a macroconidia on the external surface. SEM. Scale bar: 1 µm.
2.4. TEM Observations
Figure 5A shows a typical structure of the M. gypseum control, with glycogen rosettes close to
the plasmalemma. The cell wall is normally structured with two typical layers visible: the outer,
non-electron-transparent, mannoproteic layer and the inner, translucent layer composed primarily of
glucan and chitin (Figure 5A,B).
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mitochondria are visible. 
At 100 μg/mL, many smaller vacuoles are present and contain non-electron-dense materials. 
Glycogen is distributed in the cytoplasm, accumulating near the vacuoles (Figure 6A). The TEM 
images also show ultrastructural changes reflecting the defensive efforts of the fungus. Notably, the 
Figure 5. (A) M. gypseum control with normal mitochondria, nuclei and ribosomes. Note the glycogen
rosettes near the plasmalemma. TEM. Scale bar: 1 µm; (B) M. gypseum treated with 20 µg/mL
phenyle ylresorcinol. Glycogen, which is no l ger arranged in rosettes, is cattered throughout
cytoplasm, and the i an increased number of large vacuoles. TEM. Scale bar: 0.5 µm.
In the samples treated with the lowest concentration of phenylethylresorcinol (20 µg/mL),
the most evident feature is the increased number of large vacuoles. Glycogen, which is no longer
visible as rosettes, is scattered throughout the cytoplasm (Figure 5B), and some normally structured
mitochondria are visible.
At 100 µg/mL, many smaller vacuoles are present and contain non-electron-dense materials.
Glycogen is distributed in the cytoplasm, accumulating near the vacuoles (Figure 6A). The TEM images
also show ultrastructural changes reflecting the defensive efforts of the fungus. Notably, the number
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of vacuoles increased, resulting from the activation of autophagic phenomena in filamentous fungi.
Autophagy is primarily a pro-survival mechanism in which normal cellular components are absorbed
into vacuoles and digested as a major response to nutrient deprivation and stress. However, it can
also be induced by antifungal compounds [13,14]. Indeed, the incorporation of glycogen into vacuoles,
which was seen at the highest concentration, is a clear autophagic phenomenon that protects against
injury [15].
Figure 6B shows the possible formation of non-electron-transparent circular bodies in the
cytoplasm that are surrounded by vacuoles and subsequently appear to be segregated, as shown
in the previous figure (Figure 6C). Their incorporation into the vacuoles may have the same autophagic
purpose. After treatment with phenylethylresorcinol at 200 µg/mL, the most evident feature is the
large increase in the thickness of the cell wall, which appears to be at least twice as thick as that of the
control. This phenomenon can be seen in Figure 6C, where several layers are evident.
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Figure 6. (A) M. gypseum treated with 100 µg/mL phenylethylresorcinol. Numerous small vacuoles
containing non-electron-transparent material. Note the accumulation of glycogen near the vacuoles.
TEM. Scale b r: 1 µm; (B) am s mple. Non-electron-transparent body in the cytoplasm surrounded
by two vacuoles. TEM. Scale ba : 1 µm; (C) High magnification of the c ll wall of M. gypseum treated
with 200 µg/mL phenylethylresorcinol. Th l ge increase in the thickness of the cell wall, which
contains several layers, is evident. TEM. Scale bar: 1 µm; (D) Sample treated with the same. Numerous
small vacuoles containing dark, irregularly shaped glycogen bodies. TEM. Scale bar: 1 µm.
At the same time, the cytoplasm is very rich in ribosomes and smooth endoplasmic reticulum,
which indicates an i crease in protein and lipid metabolism. Some vacuoles have a relatively fine
electron matrix, whereas others display a matrix with darker, irregularly shaped areas that are very
opaque to electrons (Figure 6D). Finally, Figure 7 shows the presence of tr nsparent and empty cells,
a clear sign of cell death induced by the highest dose of the substance.
Another prominent observation is related to the cell wall, which is of great importance in fungus
survival [11,16]. Cell wall structure is highly dynamic, changing constantly during cell division,
growth and morphogenesis. It is generally accepted that the pattern of cell wall deposition is of
primary importance in shaping the fungal cell and that interference or damage during the assembly
of this structure negatively impacts the morphogenesis or life of the fungus [16]. Mares et al. [13]
interpret d this increas in cell wall thickness as premature and abnormal aging of the fungus.
The cell wall has not been previously described as a target of resorcinols, whereas mitochondria,
nucleic acids, proteins and, in particular, the endomembrane system are frequently reported as targets
of these molecules [4,17,18].
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3. Experimental Section
3.1. Microorganisms
The following seven fungal strains investigated in this study were purchased from the
Centraal Bureau voor Schimmelcultures (CBS; Baarn, The Netherlands): Arthroderma cajetani Ajello,
strain CBS 495.70; Epidermophyton floccosum (Hartz) Langeron and Milochevitch, strain CBS 358.93;
Trichophyton violaceum Malmsten, strain CBS 459.61; Trichophyton tonsurans Mal sten, strain CBS 483.76;
Trichophyton mentagrophytes (Robin) Blanchard, strain CBS 160.66; Microsporum canis Bodin, strain
CBS 4727; and Nannizzia gypsea (Nann.) Weitzman, McGinnis, A.A. Padhye and Ajello, strain
CBS 286.63. The remaining two strains were purchased from the Institute of Hygiene and
Epidemiology-Mycology Laboratory (IHME; Brussels, Belgium): Trichophyton rubrum (Castellani)
Sabouraud, strain IHME 4321 and Microsporum gypseum (Bodin) Guiart & Grigorakis, strain IHME 3999.
All dermatophytes were maintained at 4 ◦C as agar slants on Sabouraud dextrose agar (SDA;
Difco Laboratories, Inc., Detroit, MI, USA).
3.2. Chemicals
The tested substances—4-butylresorcinol (4-butyl-1,3-benzenediol, Acteosome), 4-hexyl-resorcinol
(4-hexyl-1,3-dihydroxybenzene, Synovea) and racemic (±)phenylethylresorcinol (4-(1-phenylethyl)-
1,3-benzenediol, Symwhite 377)—were purchased from Sigma-Aldrich SRL (Milano, Italy) and Symrise
GmbH & Co. KG (Holzminden, Germany). Resazurin, used for fixation, and solvents were also
purchased from Sigma-Aldrich SRL.
3.3. Growth Inhibition
Antifungal activity was determined as follows. Each test substance was dissolved in dimethyl
sulfoxide (DMSO), and a suitable dilution was aseptically mixed with sterile SDA medium at 45 ◦C
to obtain final concentrations of 5, 10, 20, 50, 100 and 200 µg/mL. The DMSO concentration in the
final solution was adjusted to 0.1%. Controls were also prepared with equivalent concentrations
(0.1% v/v) of DMSO. For the experiments, cultures were obtained by transplanting mycelium disks
(10 mm in diameter) from a single mother culture in the stationary phase. They were incubated at
26 ± 1 ◦C on SDA on thin sheets of cellophane until the logarithmic growth phase. Subsequently,
the cultures were transferred to Petri dishes with media containing 5, 10, 20, 50, 100 and 200 µg/mL of
the three substances and incubated under growth conditions. The fungal growth was evaluated daily
by measuring the colony diameters (in millimetres) for seven days beginning at the onset of treatment.
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The percentage inhibition of growth was determined as the average of three different
experiments. IC50 values were obtained for only the two substances that were active against the
nine dermatophytes—phenylethylresorcinol and 4-hexylresorcinol—at concentrations of 5, 10, 20, 50,
100 and 200 µg/mL. The IC50 values were calculated as the average of three different experiments,
and they indicate the concentration of the substance needed to inhibit the growth of the fungus by half.
3.4. Spore Germination Assay
3.4.1. Evaluation of Spore Germination Inhibition
The efficacies of the three resorcinol derivatives tested were evaluated by resazurin assays using
an optimized incubation time and spore density, as described by Romagnoli et al. [1]. A stock
solution of each substance was prepared in DMSO. Then, phenylethylresorcinol, 4-hexylresorcinol
and 4-butylresorcinol were added to test vials in duplicate at concentrations of 100 and 200 µg/mL.
The test vials contained the substances to be tested, 105 spore/mL (determined via previous evaluation),
and 100 µL of resazurin stock solution in Sabouraud dextrose broth. The vials were covered, gently
rotated horizontally to mix the contents and incubated in the dark at 24 ◦C for 120 h. Duplicate
negative control vials containing 10 mL of medium and 100 µL of resazurin stock solution and
duplicate positive control vials containing 10 mL of medium, 105 spore/mL and 100 µL of resazurin
stock solution were also processed. Fluorometric measurements and visual inspections were also
conducted to evaluate spore germination. Fluorescence data were expressed as the percentage of
resazurin reduced as a function of incubation time. After 24 h, the percentage of resazurin reduction
was determined fluorometrically by measuring the fluorescence at 578 nm. The absorbance was read
with a DU® 530 Life Science UV/Vis spectrophotometer (Beckman CoulterTM, Brea, CA, USA) using
a single-cell module.
The colours of the wells were also visually recorded (Figure 2). Blue was interpreted to indicate
the absence of metabolic activity (no spore germination), whereas fluorescent pink was interpreted to
indicate the presence of metabolic activity (spore germination). Purple was interpreted as a trailing
result, reflecting the presence of some metabolic activity; however, prolonging the incubation time
caused the purple colour to change to pink.
3.4.2. TEM and SEM
The youngest hyphae of M. gypseum were chosen from untreated mycelia and from mycelia treated
for 24 h with 20, 100 and 200 µg/mL phenylethylresorcinol for TEM and SEM analyses. Samples
were fixed with 6% glutaraldehyde (GA) in 0.1 M sodium cacodylate buffer, pH 6.8, for 6 h at 4 ◦C.
After rinsing in the same buffer solution, the samples for TEM were post-fixed for 15 h with 1%
osmium tetroxide (OsO4) in the same buffer, dehydrated in a graded series of alcohol and embedded
in Epon-Araldite resin. Sections were cut with an Ultratome III (LKB Instruments, Mount Waverley,
Australia) stained with uranyl acetate and lead citrate and observed with an H-800 electron microscope
at 100 kV (Hitachi, Altavilla Vicentina (VI), Italy),provided by the Electron Microscopy Center of Ferrara
University). For SEM, samples were fixed with 6% GA in 0.1 M sodium cacodylate buffer, pH 6.8,
for 6 h at 4 ◦C, briefly (1 h) post-fixed with 1% OsO4 in the same buffer, dehydrated in a graded series
of alcohol, critical point-dried and gold-coated using an S 150 sputter coater (Edwards SpA, Cinisello
Balsamo, Italy). SEM observations were collected using an EVO 40 instrument (Zeiss, Oberkochen,
Germany) provided by the Electron Microscopy Center of Ferrara University).
4. Conclusions
In conclusion, select resorcinols already in use in the dermatology field for cosmetic applications
were investigated and found to provide valuable activity against dermatophytic fungi. In particular,
phenylethylresorcinol, widely used in the racemic form (under the trade name of Symwhite 377) in
the dermo-cosmetic field as skin whitening, resulted of particular interest. These findings extend the
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application of resorcinols in medicine, especially for the treatment of human infections from soil or
pets. Although the study of their mechanisms of action cannot be considered conclusive and requires
further chemical investigations and evaluations using several different fungi, our results are of interest
regarding the development of agents endowed with specific activities towards this class of emerging
human pathogens. This study is based on a relatively safe approach that begins with the selection of
molecules whose use is already established in the dermo-cosmetic field.
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